Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: A display panel and a personal immersive device including the same are disclosed. In the display panel, any one of a first electrode and a second electrode of a light-emitting element includes: an incident-side metal layer on which light is incident; a reflective-side metal layer from which the light is reflected; and a transparent intermediate layer interposed between the incident-side metal layer and the reflective-side metal layer.

Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer, comprising an anticancer drug and a pyrrolo-pyridine derivative as an active ingredient. A compound represented by Chemical Formula I according to the present invention, an isomer thereof, or a pharmaceutically acceptable salt thereof has excellent inhibitory activity against protein kinases, and thus, when used in combination with other anticancer drugs, can be effectively used in the prevention, treatment or amelioration of cancer.

Abstract: An electroluminescent display device includes a substrate on which first and second pixel regions are defined, a passivation layer over the substrate, a first electrode in each of the first and second pixel regions on the passivation layer, a bank layer exposing the first electrode, a light emitting layer on the first electrode exposed by the bank layer, and a second electrode on the light emitting layer, further the bank layer includes first and second openings exposing the first electrodes corresponding to the first and second pixel regions, respectively, and also a depth of the second opening is larger than a depth of the first opening, and a height of the bank layer of the second pixel region is larger than a height of the bank layer of the first pixel region.

Abstract: An electroluminescent display device includes a substrate on which first and second pixel regions are defined, a passivation layer over the substrate, a first electrode in each of the first and second pixel regions on the passivation layer, a bank layer exposing the first electrode, a light emitting layer on the first electrode exposed by the bank layer, and a second electrode on the light emitting layer, further the bank layer includes first and second openings exposing the first electrodes corresponding to the first and second pixel regions, respectively, and also a depth of the second opening is larger than a depth of the first opening, and a height of the bank layer of the second pixel region is larger than a height of the bank layer of the first pixel region.

Abstract: An electroluminescent display device includes a substrate on which first and second pixel regions are defined, a passivation layer over the substrate, a first electrode in each of the first and second pixel regions on the passivation layer, a bank layer exposing the first electrode, a light emitting layer on the first electrode exposed by the bank layer, and a second electrode on the light emitting layer, wherein the bank layer includes first and second openings exposing the first electrodes corresponding to the first and second pixel regions, respectively, and a depth of the second opening is larger than a depth of the first opening.

Abstract: An electroluminescent display device includes a substrate on which first and second pixel regions are defined, a passivation layer over the substrate, a first electrode in each of the first and second pixel regions on the passivation layer, a bank layer exposing the first electrode, a light emitting layer on the first electrode exposed by the bank layer, and a second electrode on the light emitting layer, wherein the bank layer includes first and second openings exposing the first electrodes corresponding to the first and second pixel regions, respectively, and a depth of the second opening is larger than a depth of the first opening.

Abstract: The present disclosure relates to an apparatus and a method of controlling a washing machine, and the apparatus for controlling the washing machine includes a door detecting sensor configured to detect an open door of the washing machine; a driver configured to drive a drum of the washing machine; and a controller configured to recognize or determine whether the door is open from the door detecting sensor, and drive the driver to rotate the drum when the door is not open for a predetermined time after an end of a washing process of the washing machine. Accordingly, washed clothes left inside the washing machine for a long time after the end of the washing processes are managed, thereby preventing laundry having wrinkles and/or unpleasant smells or odors.